Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Eggermont

Showing results (11-20 of 171) with videos related to

Pageof 18
Sort By:
Cancer Detection and Prevention|January 1, 1990
Immunogenicity of the tumor determines the outcome of immunotherapy with interleukin-2, ABPP, and cyclophosphamide of micro- and macrometastatic intraperitoneal tumorA M Eggermont, P H Sugarbaker
Acta Medica Austriaca|January 1, 1989
Efficacy of intracavitary administration of cyclophosphamide, interleukin-2 and lymphokine activated killer cells against established intraperitoneal tumorA M Eggermont, P H Sugarbaker
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2002
Adjuvant interferon-alpha for melanoma revisited: news from old and new studiesC J Punt, A M Eggermont
Melanoma Research|February 1, 1995
Twenty-five years of pluridisciplinary approach for melanoma patients. The European Organization on Research and Treatment of Cancer Melanoma Cooperative Group (EORTC-MCG)U R Kleeberg, A M Eggermont
Current Oncology Reports|June 8, 2001
Isolated limb perfusion for extremity soft-tissue sarcomas, in-transit metastases, and other unresectable tumors: credits, debits, and future perspectivesA M Eggermont, T L ten Hagen
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2001
Interferon-alpha induced Raynaud's syndromeW H Kruit, A M Eggermont, G Stoter
Archives of Surgery (Chicago, Ill. : 1960)|December 1, 1985
Ultrasound-guided percutaneous transhepatic cholecystostomy for acute acalculous cholecystitisA M Eggermont, J S Laméris, J Jeekel
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 1, 1992
Subcutaneous tumor growth complicating the positioning of Denver shunt and intrapleural port-à-cath in mesothelioma patientsB van Ooijen, A M Eggermont, T Wiggers
Surgery|July 1, 1987
Laparotomy enhances intraperitoneal tumor growth and abrogates the antitumor effects of interleukin-2 and lymphokine-activated killer cellsA M Eggermont, E P Steller, P H Sugarbaker
European Journal of Clinical Investigation|April 15, 1999
Effects of tumour necrosis factor alpha and melphalan on the cytokine production of circulating T cells in patients with cancerT C Stam, A M Eggermont, A J Swaak
Pageof 18

Showing results (11-20 of 171) with videos related to

Sort By:
Pageof 18
Cancer Detection and Prevention|January 1, 1990
Immunogenicity of the tumor determines the outcome of immunotherapy with interleukin-2, ABPP, and cyclophosphamide of micro- and macrometastatic intraperitoneal tumorA M Eggermont, P H Sugarbaker
Acta Medica Austriaca|January 1, 1989
Efficacy of intracavitary administration of cyclophosphamide, interleukin-2 and lymphokine activated killer cells against established intraperitoneal tumorA M Eggermont, P H Sugarbaker
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2002
Adjuvant interferon-alpha for melanoma revisited: news from old and new studiesC J Punt, A M Eggermont
Melanoma Research|February 1, 1995
Twenty-five years of pluridisciplinary approach for melanoma patients. The European Organization on Research and Treatment of Cancer Melanoma Cooperative Group (EORTC-MCG)U R Kleeberg, A M Eggermont
Current Oncology Reports|June 8, 2001
Isolated limb perfusion for extremity soft-tissue sarcomas, in-transit metastases, and other unresectable tumors: credits, debits, and future perspectivesA M Eggermont, T L ten Hagen
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2001
Interferon-alpha induced Raynaud's syndromeW H Kruit, A M Eggermont, G Stoter
Archives of Surgery (Chicago, Ill. : 1960)|December 1, 1985
Ultrasound-guided percutaneous transhepatic cholecystostomy for acute acalculous cholecystitisA M Eggermont, J S Laméris, J Jeekel
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 1, 1992
Subcutaneous tumor growth complicating the positioning of Denver shunt and intrapleural port-à-cath in mesothelioma patientsB van Ooijen, A M Eggermont, T Wiggers
Surgery|July 1, 1987
Laparotomy enhances intraperitoneal tumor growth and abrogates the antitumor effects of interleukin-2 and lymphokine-activated killer cellsA M Eggermont, E P Steller, P H Sugarbaker
European Journal of Clinical Investigation|April 15, 1999
Effects of tumour necrosis factor alpha and melphalan on the cytokine production of circulating T cells in patients with cancerT C Stam, A M Eggermont, A J Swaak
Pageof 18